189 related articles for article (PubMed ID: 24423611)
1. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation.
Wang XS; Shi Q; Shah ND; Heijnen CJ; Cohen EN; Reuben JM; Orlowski RZ; Qazilbash MH; Johnson VE; Williams LA; Mendoza TR; Cleeland CS
Clin Cancer Res; 2014 Mar; 20(5):1366-74. PubMed ID: 24423611
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma.
Wang XS; Shi Q; Williams LA; Shah ND; Mendoza TR; Cohen EN; Reuben JM; Cleeland CS; Orlowski RZ
Leuk Lymphoma; 2015 May; 56(5):1335-41. PubMed ID: 25248883
[TBL] [Abstract][Full Text] [Related]
3. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation.
Wang XS; Shi Q; Williams LA; Cleeland CS; Mobley GM; Reuben JM; Lee BN; Giralt SA
Cancer; 2008 Oct; 113(8):2102-9. PubMed ID: 18792065
[TBL] [Abstract][Full Text] [Related]
4. Symptom burden after autologous stem cell transplantation for multiple myeloma.
Campagnaro E; Saliba R; Giralt S; Roden L; Mendoza F; Aleman A; Cleeland C; Weber D; Brown J; Anderson KO
Cancer; 2008 Apr; 112(7):1617-24. PubMed ID: 18260091
[TBL] [Abstract][Full Text] [Related]
5. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.
Wang XS; Williams LA; Krishnan S; Liao Z; Liu P; Mao L; Shi Q; Mobley GM; Woodruff JF; Cleeland CS
Brain Behav Immun; 2012 Jul; 26(5):699-705. PubMed ID: 22251605
[TBL] [Abstract][Full Text] [Related]
6. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial.
Deng G; Giralt S; Chung DJ; Landau H; Siman J; Search B; Coleton M; Vertosick E; Shapiro N; Chien C; Wang XS; Cassileth B; Mao JJ
Support Care Cancer; 2018 Feb; 26(2):657-665. PubMed ID: 28920142
[TBL] [Abstract][Full Text] [Related]
7. Symptom burden in patients undergoing autologous stem-cell transplantation.
Anderson KO; Giralt SA; Mendoza TR; Brown JO; Neumann JL; Mobley GM; Wang XS; Cleeland CS
Bone Marrow Transplant; 2007 Jun; 39(12):759-66. PubMed ID: 17438588
[TBL] [Abstract][Full Text] [Related]
8. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.
Shi Q; Wang XS; Li G; Shah ND; Orlowski RZ; Williams LA; Mendoza TR; Cleeland CS
Cancer; 2015 Apr; 121(7):1138-46. PubMed ID: 25469832
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.
Wang XS; Shi Q; Williams LA; Mao L; Cleeland CS; Komaki RR; Mobley GM; Liao Z
Brain Behav Immun; 2010 Aug; 24(6):968-74. PubMed ID: 20353817
[TBL] [Abstract][Full Text] [Related]
10. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis.
Shah N; Shi Q; Williams LA; Mendoza TR; Wang XS; Reuben JM; Dougherty PM; Bashir Q; Qazilbash MH; Champlin RE; Cleeland CS; Giralt SA
Biol Blood Marrow Transplant; 2016 Feb; 22(2):226-231. PubMed ID: 26253006
[TBL] [Abstract][Full Text] [Related]
11. Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study.
Kohsari M; Khadem-Ansari MH; Rasmi Y; Sayyadi H
Asian Pac J Cancer Prev; 2020 Jan; 21(1):127-132. PubMed ID: 31983174
[TBL] [Abstract][Full Text] [Related]
12. Associations of inflammation with symptom burden in patients with acute myeloid leukemia.
Lacourt TE; Kavelaars A; Galloway-Peña JR; Sahasrabhojane PV; Shah ND; Futreal A; Kontoyiannis DP; Shelburne SA; Heijnen CJ
Psychoneuroendocrinology; 2018 Mar; 89():203-208. PubMed ID: 29414033
[TBL] [Abstract][Full Text] [Related]
13. Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
Landau H; Wood K; Chung DJ; Koehne G; Lendvai N; Hassoun H; Lesokhin A; Hoover E; Zheng J; Devlin SM; Giralt S
Leuk Lymphoma; 2016 Aug; 57(8):1781-5. PubMed ID: 26758672
[TBL] [Abstract][Full Text] [Related]
14. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
15. Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial.
Wang XS; Shi Q; Mendoza TR; Garcia-Gonzalez A; Chen TY; Kamal M; Chen TH; Heijnen C; Orlowski RZ; Cleeland CS
Support Care Cancer; 2021 Oct; 29(10):6099-6107. PubMed ID: 33792800
[TBL] [Abstract][Full Text] [Related]
16. Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.
Naegele M; Kirsch M; Ihorst G; Fierz K; Engelhardt M; De Geest S
Support Care Cancer; 2018 Mar; 26(3):833-841. PubMed ID: 28918604
[TBL] [Abstract][Full Text] [Related]
17. Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study.
Musto P; Simeon V; Grossi A; Gay F; Bringhen S; Larocca A; Guariglia R; Pietrantuono G; Villani O; D'Arena G; Cuomo C; Musto C; Morabito F; Petrucci MT; Offidani M; Zamagni E; Tacchetti P; Conticello C; Milone G; Palumbo A; Cavo M; Boccadoro M
Stem Cell Res Ther; 2015 Apr; 6(1):64. PubMed ID: 25889496
[TBL] [Abstract][Full Text] [Related]
18. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.
Sadeghi M; Daniel V; Naujokat C; Wiesel M; Hergesell O; Opelz G
Transpl Int; 2005 Feb; 18(2):177-85. PubMed ID: 15691270
[TBL] [Abstract][Full Text] [Related]
19. Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.
Shah N; Shi Q; Giralt S; Williams L; Bashir Q; Qazilbash M; Champlin RE; Cleeland CS; Wang XS
Qual Life Res; 2018 Apr; 27(4):979-985. PubMed ID: 29260444
[TBL] [Abstract][Full Text] [Related]
20. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life.
Boland E; Eiser C; Ezaydi Y; Greenfield DM; Ahmedzai SH; Snowden JA
J Pain Symptom Manage; 2013 Nov; 46(5):671-80. PubMed ID: 23535325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
